Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory regulatory policy

NAFDAC boosts Nigeria local drug manufacturing

Analysis based on 8 articles · First reported Sep 06, 2026 · Last updated Sep 07, 2026

Sentiment
40
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The policy shift is expected to boost Nigeria's domestic pharmaceutical manufacturing sector, attracting investment and reducing import dependence. This could improve the country's trade balance and strengthen the local industry, though it may increase costs for import-dependent firms in the short term.

Pharmaceuticals Medical devices

NAFDAC's 5+5 Policy and Ceiling List initiatives, introduced in 2019 and expanded since, have significantly reshaped Nigeria's pharmaceutical industry by restricting imports of medicines that can be produced locally. According to NAFDAC Director-General Mojisola Adeyeye, speaking at the Lagos Chamber of Commerce and Industry's Invest in Nigeria Conference and Expo 4.0, these measures have cut imports of affected drug products by 70% and increased local manufacturing by 25%. The number of pharmaceutical manufacturing companies rose from 174 to 190, and the import-to-local production ratio improved from 70:30 in 2019 to 50:50 in 2025. Contract manufacturing expanded from 10 companies in 2019 to 87 in 2026. As of June 2026, NAFDAC had approved facility layouts for 176 pharmaceutical companies, including 106 new entrants. The agency also reported 28 newly developed or retrofitted companies and 16 new facilities, totaling 44. These developments are supported by President Bola Tinubu's 2024 Executive Order providing zero tariffs, excise duties, and VAT on imported machinery and raw materials for local healthcare manufacturing. NAFDAC is extending similar local manufacturing strategies to food and cosmetics sectors.

70 Bola Tinubu issued Executive Order Nigeria
60 United States — Food and Drug Administration reported 70% import decline
60 United States — Food and Drug Administration reported 25% local increase
50 United States — Food and Drug Administration approved 176 facility layouts
50 United States — Food and Drug Administration reported contract manufacturing growth
50 United States — Food and Drug Administration reported 44 new facilities
govactor
NAFDAC is the central regulator implementing the 5+5 Policy and Ceiling List, driving the shift to local manufacturing. Its actions have increased its regulatory influence and are seen positively for domestic industry.
Importance 100.0 Sentiment 60.0
cnt
Nigeria's pharmaceutical industry is being reshaped, with reduced import dependence and increased local production. This strengthens national drug security and attracts foreign investment, positively impacting the economy.
Importance 90.0 Sentiment 50.0
per
As NAFDAC Director-General, Adeyeye is the public face of the policy, announcing the results and urging investment. Her leadership is credited with the successful implementation.
Importance 80.0 Sentiment 60.0
per
President Tinubu's 2024 Executive Order providing fiscal incentives supports the local manufacturing push, aligning with his administration's economic diversification goals.
Importance 60.0 Sentiment 50.0
ngo
LCCI hosted the Invest in Nigeria Conference where the announcements were made, providing a platform for promoting investment in Nigeria's pharmaceutical sector.
Importance 30.0 Sentiment 30.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.